Cargando...

n-Butyl Cyanoacrylate Embolization of Cerebral Arteriovenous Malformations: Results of a Prospective, Randomized, Multi-center Trial

BACKGROUND AND PURPOSE: Liquid n-butyl cyanoacrylate (n-BCA) use for the treatment of arteriovenous malformations (AVM) in the brain has become part of medical practice. However, no study has led to the Food and Drug Administration’s approval of n-BCA for intravascular use. The purpose of this study...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:AJNR Am J Neuroradiol
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Neuroradiology 2002
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7974739/
https://ncbi.nlm.nih.gov/pubmed/12006271
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!